Brief: Amarantus Subsidiary Elto Pharma Receives Notice Of Allowance Covering Use Of Eltoprazine Combined With CBD To Treat Parkinson's Disease

Amarantus Bioscience Holdings

04/12/2019 12:40

Dec 4 (Reuters) - Amarantus Bioscience Holdings Inc
 AMBS.PK :
    * AMARANTUS SUBSIDIARY ELTO PHARMA RECEIVES NOTICE OF
ALLOWANCE
COVERING USE OF ELTOPRAZINE COMBINED WITH CBD TO TREAT
PARKINSON'S DISEASE

Source text for Eikon:  ID:nGNX82CN2q 
Further company coverage:  AMBS.PK 

 (Reporting by Dominic Roshan K L)
 ((Dominic.RoshanKL@thomsonreuters.com;))